Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Jae Moon Koh"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Expression of c-MET in Invasive Meningioma
Sumi Yun, Jae Moon Koh, Kyu Sang Lee, An Na Seo, Kyung Han Nam, Gheeyoung Choe
J Pathol Transl Med. 2015;49(1):44-51.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.13
  • 9,127 View
  • 67 Download
  • 23 Web of Science
  • 20 Crossref
AbstractAbstract PDF
Background
Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have been reported to be involved in cancer invasion. Methods: We examined the immunohistochemical expression of c-MET and HGF in 100 cases of patients with meningiomas who have undergone complete tumor removal. Results: c-MET-High and HGFHigh were found in 17% and 13% of meningiomas, respectively. Brain invasion was observed in 17.6% of c-MET-High meningiomas, but in only 2.4% of c-MET-Low meningiomas (p=.033). Bone/ soft tissue invasion was observed in 23.5% of c-MET-High meningiomas and in 9.6% of c-MET-Low meningiomas (p=.119). HGF-High did not show statistical association with brain invasion or bone/ soft tissue invasion. c-MET-High demonstrated shorter recurrence-free survival (RFS, 93.5±8.2 months vs 96.1±1.9 months); however, this difference was not statistically significant (p=.139). There was no association of HGF-High with RFS. Conclusions: This study demonstrates that c- MET-High is associated with brain invasion of meningiomas, and that c-MET expression may be a useful predictive marker for meningioma recurrence. Patients with invasive meningiomas with high expressions of c-MET may be good candidates for targeted therapy using c-MET inhibitors.

Citations

Citations to this article as recorded by  
  • Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
    Swati Sharma, Rashmi Rana, Prem Prakash, Nirmal Kumar Ganguly
    Molecular and Cellular Biochemistry.2024; 479(1): 127.     CrossRef
  • The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
    Jun Jiang, Juan Yu, Xiajing Liu, Kan Deng, Kaichao Zhuang, Fan Lin, Liangping Luo
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review
    Ataollah Shahbandi, Darsh S. Shah, Caroline C. Hadley, Akash J. Patel
    Cancers.2023; 15(2): 483.     CrossRef
  • Advances in the systemic therapy for recurrent meningiomas and the challenges ahead
    Yi Li, Jan Drappatz
    Expert Review of Neurotherapeutics.2023; 23(11): 995.     CrossRef
  • Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases
    Thiébaud Picart, Chloé Dumot, Jacques Guyotat, Vladislav Pavlov, Nathalie Streichenberger, Alexandre Vasiljevic, Tanguy Fenouil, Anne Durand, Emmanuel Jouanneau, François Ducray, Timothée Jacquesson, Moncef Berhouma, David Meyronet
    Neurosurgical Review.2022; 45(4): 2797.     CrossRef
  • Nomogram based on MRI can preoperatively predict brain invasion in meningioma
    Jing Zhang, Yuntai Cao, Guojin Zhang, Zhiyong Zhao, Jianqing Sun, Wenyi Li, Jialiang Ren, Tao Han, Junlin Zhou, Kuntao Chen
    Neurosurgical Review.2022; 45(6): 3729.     CrossRef
  • Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma
    Farhad Mashayekhi, Soheila Talesh Sasani, Alia Saberi, Zivar Salehi
    Journal of Clinical Neuroscience.2021; 93: 1.     CrossRef
  • Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options
    Chaoying Qin, Meng Huang, Yimin Pan, Yuzhe Li, Wenyong Long, Qing Liu
    Brain Tumor Pathology.2021; 38(3): 156.     CrossRef
  • YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas
    Kathleen M. Schieffer, Vibhuti Agarwal, Stephanie LaHaye, Katherine E. Miller, Daniel C. Koboldt, Tara Lichtenberg, Kristen Leraas, Patrick Brennan, Benjamin J. Kelly, Erin Crist, Jerome Rusin, Jonathan L. Finlay, Diana S. Osorio, Eric A. Sribnick, Jeffre
    American Journal of Surgical Pathology.2021; 45(3): 329.     CrossRef
  • Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
    Rupesh Kotecha, Raees Tonse, Haley Appel, Yazmin Odia, Ritesh R. Kotecha, Guilherme Rabinowits, Minesh P. Mehta
    Current Oncology.2021; 28(2): 1537.     CrossRef
  • Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis
    Satoshi Nakasu, Yoko Nakasu
    Brain Tumor Pathology.2021; 38(2): 81.     CrossRef
  • Curcumin Inhibits HGF-Induced EMT by Regulating c-MET-Dependent PI3K/Akt/mTOR Signaling Pathways in Meningioma
    Xiaodong Chen, Fen Tian, Peng Lun, Yugong Feng, Ho Lin
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • Letter to the Editor. Preoperative seizures as predictive sign of brain invasion by meningioma
    Mikhail F. Chernov
    Journal of Neurosurgery.2019; 130(3): 1030.     CrossRef
  • Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection
    Yoon Ah Cho, Ji Myung Chung, Hyunmi Ryu, Eun Kyung Kim, Byoung Chul Cho, Sun Och Yoon
    Cancer Research and Treatment.2019; 51(3): 1052.     CrossRef
  • Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging
    Alborz Adeli, Katharina Hess, Christian Mawrin, Eileen Maria Susanne Streckert, Walter Stummer, Werner Paulus, André Kemmling, Markus Holling, Walter Heindel, Rene Schmidt, Dorothee Cäcilia Spille, Peter B. Sporns, Benjamin Brokinkel
    Oncotarget.2018; 9(89): 35974.     CrossRef
  • Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature
    A. Paix, W. Waissi, D. Antoni, R. Adeduntan, G. Noël
    Cancer/Radiothérapie.2017; 21(1): 55.     CrossRef
  • Letter: Brain Invasion in Meningiomas—Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression
    Katharina Heß, Dorothee Cäcilia Spille, Andrea Wagner, Walter Stummer, Werner Paulus, Benjamin Brokinkel
    Neurosurgery.2017; 81(2): E25.     CrossRef
  • Brain invasion in meningiomas—clinical considerations and impact of neuropathological evaluation: a systematic review
    Benjamin Brokinkel, Katharina Hess, Christian Mawrin
    Neuro-Oncology.2017; 19(10): 1298.     CrossRef
  • Systemic therapy for recurrent meningioma
    E. Le Rhun, S. Taillibert, M. C. Chamberlain
    Expert Review of Neurotherapeutics.2016; 16(8): 889.     CrossRef
  • Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis
    Dorothee Cäcilia Spille, Katharina Heß, Cristina Sauerland, Nader Sanai, Walter Stummer, Werner Paulus, Benjamin Brokinkel
    World Neurosurgery.2016; 93: 346.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine